| Name | Title | Contact Details |
|---|
Named a Top 20 Leadership Training Company, VitalSmarts combines three decades of original research with 50 years of the best social science thinking to help leaders and organizations achieve new levels of performance. Specifically, we focus on human behavior—the underlying written and unwritten rules that shape employee behavior and the organizational culture. VitalSmarts` work within the halls of some of the world`s top organizations has led us to identify four skill sets present in successful companies. When used in combination, these high-leverage skills create healthy corporate cultures that spur flawless execution and consistent innovation. These skill sets are taught in the New York Times bestselling books and award-winning training programs of the same titles: Crucial Conversations®, Crucial Accountability®, Getting Things Done®, and Influencer Training®. VitalSmarts has trained two million people worldwide and helped more than 300 of the Fortune 500 realize significant results using this proven method for driving rapid, sustainable and measurable change in behaviors. VitalSmarts has been ranked by Inc. magazine as one of the fastest-growing companies in America for ten consecutive years.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.
Consolidated Abaddon Resources Inc. is a Vancouver, BC-based company in the Business Services sector.
Echo 24 is a Reynoldsburg, OH-based company in the Business Services sector.
ARTMUNN is a California, MD-based company in the Business Services sector.